Global Recombinant Human Serum Albumin Supply, Demand and Key Producers, 2023-2029

Global Recombinant Human Serum Albumin Supply, Demand and Key Producers, 2023-2029

The global Recombinant Human Serum Albumin market size is expected to reach $ 122.5 million by 2029, rising at a market growth of 6.9% CAGR during the forecast period (2023-2029).

Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.

Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.

Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.

This report studies the global Recombinant Human Serum Albumin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Human Serum Albumin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Serum Albumin that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Recombinant Human Serum Albumin total production and demand, 2018-2029, (Kg)

Global Recombinant Human Serum Albumin total production value, 2018-2029, (USD Million)

Global Recombinant Human Serum Albumin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Kg)

Global Recombinant Human Serum Albumin consumption by region & country, CAGR, 2018-2029 & (Kg)

U.S. VS China: Recombinant Human Serum Albumin domestic production, consumption, key domestic manufacturers and share

Global Recombinant Human Serum Albumin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Kg)

Global Recombinant Human Serum Albumin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Kg)

Global Recombinant Human Serum Albumin production by Application production, value, CAGR, 2018-2029, (USD Million) & (Kg).

This reports profiles key players in the global Recombinant Human Serum Albumin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen and HiMedia, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Serum Albumin market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kg) and average price (US$/g) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Human Serum Albumin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Recombinant Human Serum Albumin Market, Segmentation by Type
OsrHSA
ScrHSA

Global Recombinant Human Serum Albumin Market, Segmentation by Application
Cell Culture Media
Medical Supplements
Other

Companies Profiled:
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia

Key Questions Answered

1. How big is the global Recombinant Human Serum Albumin market?

2. What is the demand of the global Recombinant Human Serum Albumin market?

3. What is the year over year growth of the global Recombinant Human Serum Albumin market?

4. What is the production and production value of the global Recombinant Human Serum Albumin market?

5. Who are the key producers in the global Recombinant Human Serum Albumin market?